Cysteine Hydrochloride

盐酸半胱氨酸

Report date: 2024/05/29 09:39:38
NME

Base Information

Drug NameCysteine Hydrochloride
Drug Alias Name半胱氨酸盐酸盐cysteinumAV-001(Avadel Pharmaceuticals)
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionAmino acid replacements
TargetsNot applicable
Therapy Area/IndicationsDietary SupplementCorneal DiseasesProtoporphyria, Erythropoietic +[4] 
Global Approved IndicationsCorneal DiseasesNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1971/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesExela Pharma Sciences LlcShaanxi Xingbang Pharmacevtical Co Ltd
Inactive CompaniesThe Brigham and Women's Hospital
Active IndicationsDietary SupplementCorneal DiseasesNeoplasms
Inactive IndicationsProtoporphyria, Erythropoietic

Other Information

ATC CodeA16AA
Related LinksWikipediaDrugBankKEGG